{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CPHRF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CPHRF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPHRF\",,,,,undefined,":{"symbol":"CPHRF","market":"US","secType":"STK","nameCN":"Cipher Pharmaceuticals, Inc.","latestPrice":11.61,"timestamp":1782396155768,"preClose":11.43,"halted":0,"volume":201,"delay":15,"changeRate":0.015748031496062968,"floatShares":14493422,"shares":25340135,"eps":1.192606,"marketStatus":"Trading","change":0.18,"latestTime":"06-25 10:02:35 EDT Delay","open":11.61,"high":11.61,"low":11.61,"amount":2333.37,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.192606,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1782417600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1533528000000,"exchange":"OTCQX","adjPreClose":11.43,"volumeRatio":0.409668},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CPHRF\",,,,,undefined,":{"symbol":"CPHRF","floatShares":14493422,"roa":"7.90%","roe":"25.94%","lyrEps":1.049641,"volumeRatio":0.409668,"shares":25340135,"dividePrice":0,"high":11.61,"amplitude":0,"preClose":11.43,"low":11.61,"week52Low":8.6353,"pbRate":"2.22","psRate":"5.78","week52High":15,"institutionHeld":0,"latestPrice":11.61,"eps":1.192606,"divideRate":0,"volume":201,"delay":15,"ttmEps":1.192606,"open":11.61,"prevYearClose":10.98,"prevWeekClose":11.41,"prevMonthClose":12,"prevQuarterClose":13.06,"fiveDayClose":11.56,"twentyDayClose":11.8735,"sixtyDayClose":13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CPHRF\",params:#limit:5,,,undefined,":[{"date":"2024-05-09","symbol":"CPHRF","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715284800000,"name":null,"time":"Post Market","dateTimestamp":1715227200000,"actualEps":null},{"market":"US","date":"2024-03-14","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710388800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-10","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668056400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-03-17","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1647489600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2021-03-18","symbol":"CPHRF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1616040000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CPHRF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CPHRF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6,"hold":0.4,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1778558400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CPHRF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644080240","title":"Press Release: Cipher Pharmaceuticals Announces Results of Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2644080240","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644080240?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:00","pubTimestamp":1781802000,"startTime":"0","endTime":"0","summary":"MISSISSAUGA, ON, June 18, 2026 /CNW/ - Cipher Pharmaceuticals Inc.    announced that it held its annual general meeting of shareholders earlier today and that all matters put forward before shareholders for consideration and approval as set out in the Company's management information circular dated May 11, 2026 were approved by the requisite majority of votes cast at the meeting. In particular, shareholders approved the election of all director nominees and the re-approval of RSM Canada LLP as auditor of the Company. A total of approximately 14.65 million shares, representing approximately 57.71% of the total shares outstanding were represented in person or by proxy at the meeting. The detailed results of the vote for the election of directors of Cipher is set out below:. Nominee           Votes For   % Votes For  Votes Withheld  % Votes Withheld. Craig Mull        13,347,449      97.02 %         410,470            2.98 %. Douglas Deeth     13,738,672      99.86 %          19,247      ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPHRF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634727282","title":"Stifel Nicolaus Remains a Buy on Cipher Pharmaceuticals (CPHRF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634727282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634727282?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:28","pubTimestamp":1778506138,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Keywood from Stifel Nicolaus maintained a Buy rating on Cipher Pharmaceuticals, with a price target of C$21.00. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-cipher-pharmaceuticals-cphrf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-remains-a-buy-on-cipher-pharmaceuticals-cphrf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","SF","CPHRF","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633417792","title":"Press Release: Cipher Pharmaceuticals Reports First Quarter Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633417792","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633417792?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:00","pubTimestamp":1778187600,"startTime":"0","endTime":"0","summary":"-- Adjusted EBITDA1 of $7.7 million in Q1 2026, a sequential increase of 10%. over Q4 2025 and a year-over-year increase of 25% compared to Q1 2025. -- Revolving credit facility fully repaid during Q1 2026; remaining cash. MISSISSAUGA, ON, May 7, 2026 /CNW/ - Cipher Pharmaceuticals Inc.    today announced its financial and operating results for the three months ended March 31, 2026.-- Net income of $6.2 million, compared to $2.6 million in Q1 2025, an. -- Basic earnings per share of $0.24, compared to $0.10 in Q1 2025, an. -- Licensing revenue increased 52% to $1.1 million, compared to $0.7 million. Craig Mull, Interim CEO, commented: \"Having achieved our goal of doubling Cipher's revenue and earnings in 2025, we are focused on securing Cipher's next leg of growth in 2026. We continue to dedicate a great deal of our time identifying, evaluating and pursuing various business development opportunities as we search for an opportunity that is the right fit for Cipher. Although these activi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4581","ET","TM","BK4144","03160","CPHRF","BK4604","BK4555","BK4588","BK4561","BK4590","BK4007","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CPHRF\",params:#limit:6,delay:false,,,undefined,":[]}}